Brief: Vistagen Therapeutics Implements 20% Workforce Reduction
11/03/2026 11:14
March 11 (Reuters) - VistaGen Therapeutics Inc VTGN.O: VISTAGEN THERAPEUTICS INC - IMPLEMENTS 20% WORKFORCE REDUCTION ON MARCH 5, 2026 - SEC FILING VISTAGEN THERAPEUTICS INC - REDUCTION SUPPORTS CASH MANAGEMENT AND PALISADE PROGRAM CLINICAL STUDIES - SEC FILING VISTAGEN THERAPEUTICS INC - EXPECTS COSTS FROM WORKFORCE REDUCTION TO BE IMMATERIAL - SEC FILING VISTAGEN THERAPEUTICS INC - EXPECTS CASH RUNWAY INTO 2027 - SEC FILING VISTAGEN THERAPEUTICS INC - AFFECTED EMPLOYEES MAY RECEIVE CASH SEVERANCE AND TEMPORARY HEALTHCARE COVERAGE - SEC FILING Source text: [ID:n0001628280-26-016652] Further company coverage: VTGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors